Downregulation of hepatic glucose-6-phosphatase-α in patients with hepatic steatosis

Obesity

Volumn 19, Issue 12, 2011, Pages 2322-2326

  Konopelska, Sarah ^a   Kienitz, Tina ^a   Quinkler, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATASE ALPHA; GLUCOSE 6 PHOSPHATE TRANSPORTER; LIPID; LIVER ENZYME; MESSENGER RNA; PHOSPHATE TRANSPORTER; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FAT CONTENT; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; INSULIN RESISTANCE; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIVER BIOPSY; MALE; MOLECULAR MECHANICS; NONALCOHOLIC FATTY LIVER; NONFATTY LIVER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; WAIST HIP RATIO;

ADIPOSE TISSUE; ADULT; ANTIPORTERS; BIOPSY; CHOLESTEROL; DOWN-REGULATION; FATTY LIVER; FEMALE; GLUCOSE-6-PHOSPHATASE; HUMANS; LIVER; MALE; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; OVERWEIGHT; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

RATTUS;

EID: 81855182087     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.118     Document Type: Article

References (26)

1. Hers HG, Berthet J, Berthet L, de Duve C. The hexose-phosphatase system. III. Intracellular localization of enzymes by fractional centrifugation. Bull Soc Chim Biol 1951;33:21-41.
2. Hers HG, de Duve C. The hexosephosphatase system; partition of activity of glucose-6-phosphatase in the tissues. Bull Soc Chim Biol 1950;32:20-29.
3. Arion WJ, Wallin BK, Lange AJ, Ballas LM. On the involvement of a glucose 6-phosphate transport system in the function of microsomal glucose 6-phosphatase. Mol Cell Biochem 1975;6:75-83.
4. Van Schaftingen E, Gerin I. The glucose-6-phosphatase system. Biochem J 2002;362:513-532.
5. Argaud D, Zhang Q, Pan W et al. Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: gene structure and 5'-flanking sequence. Diabetes 1996;45:1563-1571.
6. Liu Z, Barrett EJ, Dalkin AC, Zwart AD, Chou JY. Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level. Biochem Biophys Res Commun 1994;205:680-686.
7. Chatelain F, Pégorier JP, Minassian C et al. Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: in vivo and in vitro studies in cultured fetal hepatocytes. Diabetes 1998;47:882-889.
8. Massillon D, Barzilai N, Hawkins M, Prus-Wertheimer D, Rossetti L. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes 1997;46:153-157.
9. Narisawa K, Igarashi Y, Otomo H, Tada K. A new variant of glycogen storage disease type I probably due to a defect in the glucose-6-phosphate transport system. Biochem Biophys Res Commun 1978;83:1360-1364.
10. Levy E, Thibault L, Turgeon J et al. Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I. Am J Clin Nutr 1993;57:922-929.
11. Bandsma RH, Wiegman CH, Herling AW et al. Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats. Diabetes 2001;50:2591-2597.
12. Bugianesi E, Gastaldelli A, Vanni E et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005;48:634-642.
13. Deivanayagam S, Mohammed BS, Vitola BE et al. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am J Clin Nutr 2008;88:257-262.
14. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-871.
15. Bellentani S, Saccoccio G, Masutti F et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:112-117.
16. Gupte P, Amarapurkar D, Agal S et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004;19:854-858.
17. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346: 1221-1231.
18. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960-967.
19. Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008;134:1682-1698.
20. Matteoni CA, Younossi ZM, Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
21. Duvnjak M, Lerotic I, Barsic N et al. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol 2007;13: 4539-4550.
22. Bánhegyi G, Benedetti A, Fulceri R, Senesi S. Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. J Biol Chem 2004;279:27017-27021.
23. Danièle N, Bordet JC, Mithieux G. Unsaturated fatty acids associated with glycogen may inhibit glucose-6 phosphatase in rat liver. J Nutr 1997;127:2289-2292.
24. Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 2008;28:370-379.
25. Metzger S, Goldschmidt N, Barash V et al. Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels. Am J Physiol 1997;273:E262-E267.
26. Grempler R, Kienitz A, Werner T et al. Tumour necrosis factor alpha decreases glucose-6-phosphatase gene expression by activation of nuclear factor kappaB. Biochem J 2004;382:471-479.